nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Mercaptopurine—ulcerative colitis	0.634	1	CbGbCtD
Brimonidine—Clonidine—SLC22A4—ulcerative colitis	0.00413	0.513	CrCbGaD
Brimonidine—Clonidine—SLC22A5—ulcerative colitis	0.0031	0.385	CrCbGaD
Brimonidine—Clonidine—ABCB1—ulcerative colitis	0.000821	0.102	CrCbGaD
Brimonidine—Conjunctivitis—Betamethasone—ulcerative colitis	0.000293	0.000868	CcSEcCtD
Brimonidine—Arrhythmia—Prednisolone—ulcerative colitis	0.00029	0.000858	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000288	0.000854	CcSEcCtD
Brimonidine—Visual impairment—Methylprednisolone—ulcerative colitis	0.000287	0.000849	CcSEcCtD
Brimonidine—Hypersensitivity—Budesonide—ulcerative colitis	0.000287	0.000849	CcSEcCtD
Brimonidine—Insomnia—Mesalazine—ulcerative colitis	0.000286	0.000847	CcSEcCtD
Brimonidine—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000286	0.000847	CcSEcCtD
Brimonidine—Paraesthesia—Mesalazine—ulcerative colitis	0.000284	0.000841	CcSEcCtD
Brimonidine—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000283	0.000838	CcSEcCtD
Brimonidine—Erythema—Prednisolone—ulcerative colitis	0.000282	0.000836	CcSEcCtD
Brimonidine—Dyspnoea—Mesalazine—ulcerative colitis	0.000282	0.000835	CcSEcCtD
Brimonidine—Somnolence—Mesalazine—ulcerative colitis	0.000281	0.000833	CcSEcCtD
Brimonidine—Asthenia—Budesonide—ulcerative colitis	0.000279	0.000827	CcSEcCtD
Brimonidine—Dyspepsia—Mesalazine—ulcerative colitis	0.000279	0.000825	CcSEcCtD
Brimonidine—Eye disorder—Methylprednisolone—ulcerative colitis	0.000278	0.000823	CcSEcCtD
Brimonidine—Mental disorder—Hydrocortisone—ulcerative colitis	0.000278	0.000822	CcSEcCtD
Brimonidine—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000276	0.000818	CcSEcCtD
Brimonidine—Erythema—Hydrocortisone—ulcerative colitis	0.000276	0.000816	CcSEcCtD
Brimonidine—Bradycardia—Dexamethasone—ulcerative colitis	0.000276	0.000816	CcSEcCtD
Brimonidine—Bradycardia—Betamethasone—ulcerative colitis	0.000276	0.000816	CcSEcCtD
Brimonidine—Pruritus—Budesonide—ulcerative colitis	0.000275	0.000815	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000273	0.000809	CcSEcCtD
Brimonidine—Fatigue—Mesalazine—ulcerative colitis	0.000273	0.000808	CcSEcCtD
Brimonidine—Pain—Mesalazine—ulcerative colitis	0.000271	0.000801	CcSEcCtD
Brimonidine—Angiopathy—Methylprednisolone—ulcerative colitis	0.00027	0.000799	CcSEcCtD
Brimonidine—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000269	0.000796	CcSEcCtD
Brimonidine—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000268	0.000794	CcSEcCtD
Brimonidine—Arrhythmia—Triamcinolone—ulcerative colitis	0.000267	0.000789	CcSEcCtD
Brimonidine—Vision blurred—Prednisolone—ulcerative colitis	0.000266	0.000788	CcSEcCtD
Brimonidine—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000266	0.000787	CcSEcCtD
Brimonidine—Depression—Prednisone—ulcerative colitis	0.000262	0.000775	CcSEcCtD
Brimonidine—Visual impairment—Dexamethasone—ulcerative colitis	0.000261	0.000772	CcSEcCtD
Brimonidine—Visual impairment—Betamethasone—ulcerative colitis	0.000261	0.000772	CcSEcCtD
Brimonidine—Mental disorder—Methylprednisolone—ulcerative colitis	0.000261	0.000772	CcSEcCtD
Brimonidine—Erythema—Triamcinolone—ulcerative colitis	0.00026	0.000769	CcSEcCtD
Brimonidine—Erythema—Methylprednisolone—ulcerative colitis	0.000259	0.000767	CcSEcCtD
Brimonidine—Dizziness—Budesonide—ulcerative colitis	0.000257	0.000762	CcSEcCtD
Brimonidine—Hypersensitivity—Azathioprine—ulcerative colitis	0.000256	0.000758	CcSEcCtD
Brimonidine—Dysgeusia—Triamcinolone—ulcerative colitis	0.000254	0.000753	CcSEcCtD
Brimonidine—Syncope—Prednisolone—ulcerative colitis	0.000253	0.00075	CcSEcCtD
Brimonidine—Eye disorder—Dexamethasone—ulcerative colitis	0.000253	0.000749	CcSEcCtD
Brimonidine—Eye disorder—Betamethasone—ulcerative colitis	0.000253	0.000749	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisolone—ulcerative colitis	0.000248	0.000735	CcSEcCtD
Brimonidine—Syncope—Hydrocortisone—ulcerative colitis	0.000247	0.000732	CcSEcCtD
Brimonidine—Angiopathy—Dexamethasone—ulcerative colitis	0.000246	0.000727	CcSEcCtD
Brimonidine—Angiopathy—Betamethasone—ulcerative colitis	0.000246	0.000727	CcSEcCtD
Brimonidine—Rash—Budesonide—ulcerative colitis	0.000245	0.000726	CcSEcCtD
Brimonidine—Dermatitis—Budesonide—ulcerative colitis	0.000245	0.000726	CcSEcCtD
Brimonidine—Headache—Budesonide—ulcerative colitis	0.000244	0.000722	CcSEcCtD
Brimonidine—Hypertension—Prednisolone—ulcerative colitis	0.000244	0.000722	CcSEcCtD
Brimonidine—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000242	0.000718	CcSEcCtD
Brimonidine—Arrhythmia—Dexamethasone—ulcerative colitis	0.000242	0.000716	CcSEcCtD
Brimonidine—Arrhythmia—Betamethasone—ulcerative colitis	0.000242	0.000716	CcSEcCtD
Brimonidine—Bradycardia—Prednisone—ulcerative colitis	0.00024	0.00071	CcSEcCtD
Brimonidine—Hypertension—Hydrocortisone—ulcerative colitis	0.000238	0.000705	CcSEcCtD
Brimonidine—Discomfort—Prednisolone—ulcerative colitis	0.000238	0.000703	CcSEcCtD
Brimonidine—Erythema—Dexamethasone—ulcerative colitis	0.000236	0.000697	CcSEcCtD
Brimonidine—Erythema—Betamethasone—ulcerative colitis	0.000236	0.000697	CcSEcCtD
Brimonidine—Myalgia—Hydrocortisone—ulcerative colitis	0.000235	0.000695	CcSEcCtD
Brimonidine—Anxiety—Hydrocortisone—ulcerative colitis	0.000234	0.000693	CcSEcCtD
Brimonidine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000233	0.00069	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000233	0.00069	CcSEcCtD
Brimonidine—Syncope—Triamcinolone—ulcerative colitis	0.000233	0.000689	CcSEcCtD
Brimonidine—Syncope—Methylprednisolone—ulcerative colitis	0.000232	0.000688	CcSEcCtD
Brimonidine—Discomfort—Hydrocortisone—ulcerative colitis	0.000232	0.000687	CcSEcCtD
Brimonidine—Nausea—Budesonide—ulcerative colitis	0.000231	0.000684	CcSEcCtD
Brimonidine—Oedema—Prednisolone—ulcerative colitis	0.00023	0.000682	CcSEcCtD
Brimonidine—Dizziness—Azathioprine—ulcerative colitis	0.00023	0.00068	CcSEcCtD
Brimonidine—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000228	0.000676	CcSEcCtD
Brimonidine—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000228	0.000674	CcSEcCtD
Brimonidine—Asthenia—Mesalazine—ulcerative colitis	0.000227	0.000672	CcSEcCtD
Brimonidine—Shock—Prednisolone—ulcerative colitis	0.000227	0.000671	CcSEcCtD
Brimonidine—Cough—Triamcinolone—ulcerative colitis	0.000227	0.000671	CcSEcCtD
Brimonidine—Oedema—Hydrocortisone—ulcerative colitis	0.000225	0.000666	CcSEcCtD
Brimonidine—Tachycardia—Prednisolone—ulcerative colitis	0.000225	0.000666	CcSEcCtD
Brimonidine—Hypertension—Triamcinolone—ulcerative colitis	0.000224	0.000664	CcSEcCtD
Brimonidine—Pruritus—Mesalazine—ulcerative colitis	0.000224	0.000663	CcSEcCtD
Brimonidine—Hypertension—Methylprednisolone—ulcerative colitis	0.000224	0.000662	CcSEcCtD
Brimonidine—Infection—Hydrocortisone—ulcerative colitis	0.000224	0.000662	CcSEcCtD
Brimonidine—Shock—Hydrocortisone—ulcerative colitis	0.000221	0.000656	CcSEcCtD
Brimonidine—Myalgia—Triamcinolone—ulcerative colitis	0.000221	0.000654	CcSEcCtD
Brimonidine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000221	0.000653	CcSEcCtD
Brimonidine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000221	0.000653	CcSEcCtD
Brimonidine—Myalgia—Methylprednisolone—ulcerative colitis	0.000221	0.000653	CcSEcCtD
Brimonidine—Eye disorder—Prednisone—ulcerative colitis	0.00022	0.000652	CcSEcCtD
Brimonidine—Anxiety—Methylprednisolone—ulcerative colitis	0.00022	0.000651	CcSEcCtD
Brimonidine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00022	0.00065	CcSEcCtD
Brimonidine—Rash—Azathioprine—ulcerative colitis	0.000219	0.000649	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000219	0.000648	CcSEcCtD
Brimonidine—Dermatitis—Azathioprine—ulcerative colitis	0.000219	0.000648	CcSEcCtD
Brimonidine—Flushing—Prednisone—ulcerative colitis	0.000219	0.000648	CcSEcCtD
Brimonidine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000219	0.000647	CcSEcCtD
Brimonidine—Discomfort—Triamcinolone—ulcerative colitis	0.000218	0.000647	CcSEcCtD
Brimonidine—Discomfort—Methylprednisolone—ulcerative colitis	0.000218	0.000645	CcSEcCtD
Brimonidine—Headache—Azathioprine—ulcerative colitis	0.000218	0.000644	CcSEcCtD
Brimonidine—Dry mouth—Triamcinolone—ulcerative colitis	0.000216	0.00064	CcSEcCtD
Brimonidine—Angiopathy—Prednisone—ulcerative colitis	0.000214	0.000633	CcSEcCtD
Brimonidine—Immune system disorder—Prednisone—ulcerative colitis	0.000213	0.00063	CcSEcCtD
Brimonidine—Oedema—Triamcinolone—ulcerative colitis	0.000212	0.000627	CcSEcCtD
Brimonidine—Syncope—Dexamethasone—ulcerative colitis	0.000211	0.000626	CcSEcCtD
Brimonidine—Syncope—Betamethasone—ulcerative colitis	0.000211	0.000626	CcSEcCtD
Brimonidine—Arrhythmia—Prednisone—ulcerative colitis	0.000211	0.000623	CcSEcCtD
Brimonidine—Infection—Triamcinolone—ulcerative colitis	0.000211	0.000623	CcSEcCtD
Brimonidine—Hypotension—Hydrocortisone—ulcerative colitis	0.00021	0.000623	CcSEcCtD
Brimonidine—Infection—Methylprednisolone—ulcerative colitis	0.00021	0.000622	CcSEcCtD
Brimonidine—Dizziness—Mesalazine—ulcerative colitis	0.000209	0.00062	CcSEcCtD
Brimonidine—Shock—Triamcinolone—ulcerative colitis	0.000209	0.000617	CcSEcCtD
Brimonidine—Insomnia—Prednisolone—ulcerative colitis	0.000208	0.000617	CcSEcCtD
Brimonidine—Shock—Methylprednisolone—ulcerative colitis	0.000208	0.000616	CcSEcCtD
Brimonidine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000207	0.000614	CcSEcCtD
Brimonidine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000207	0.000613	CcSEcCtD
Brimonidine—Loss of consciousness—Betamethasone—ulcerative colitis	0.000207	0.000613	CcSEcCtD
Brimonidine—Paraesthesia—Prednisolone—ulcerative colitis	0.000207	0.000613	CcSEcCtD
Brimonidine—Tachycardia—Triamcinolone—ulcerative colitis	0.000207	0.000612	CcSEcCtD
Brimonidine—Mental disorder—Prednisone—ulcerative colitis	0.000207	0.000611	CcSEcCtD
Brimonidine—Nausea—Azathioprine—ulcerative colitis	0.000206	0.000611	CcSEcCtD
Brimonidine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000206	0.000611	CcSEcCtD
Brimonidine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000205	0.000608	CcSEcCtD
Brimonidine—Erythema—Prednisone—ulcerative colitis	0.000205	0.000607	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000205	0.000607	CcSEcCtD
Brimonidine—Insomnia—Hydrocortisone—ulcerative colitis	0.000204	0.000603	CcSEcCtD
Brimonidine—Hypertension—Betamethasone—ulcerative colitis	0.000203	0.000602	CcSEcCtD
Brimonidine—Hypertension—Dexamethasone—ulcerative colitis	0.000203	0.000602	CcSEcCtD
Brimonidine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000202	0.000598	CcSEcCtD
Brimonidine—Myalgia—Dexamethasone—ulcerative colitis	0.000201	0.000594	CcSEcCtD
Brimonidine—Myalgia—Betamethasone—ulcerative colitis	0.000201	0.000594	CcSEcCtD
Brimonidine—Anxiety—Dexamethasone—ulcerative colitis	0.0002	0.000592	CcSEcCtD
Brimonidine—Anxiety—Betamethasone—ulcerative colitis	0.0002	0.000592	CcSEcCtD
Brimonidine—Rash—Mesalazine—ulcerative colitis	0.0002	0.000591	CcSEcCtD
Brimonidine—Dermatitis—Mesalazine—ulcerative colitis	0.000199	0.00059	CcSEcCtD
Brimonidine—Headache—Mesalazine—ulcerative colitis	0.000198	0.000587	CcSEcCtD
Brimonidine—Discomfort—Dexamethasone—ulcerative colitis	0.000198	0.000587	CcSEcCtD
Brimonidine—Discomfort—Betamethasone—ulcerative colitis	0.000198	0.000587	CcSEcCtD
Brimonidine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000198	0.000587	CcSEcCtD
Brimonidine—Hypotension—Methylprednisolone—ulcerative colitis	0.000198	0.000585	CcSEcCtD
Brimonidine—Pain—Prednisolone—ulcerative colitis	0.000197	0.000583	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000194	0.000575	CcSEcCtD
Brimonidine—Fatigue—Hydrocortisone—ulcerative colitis	0.000194	0.000574	CcSEcCtD
Brimonidine—Vision blurred—Prednisone—ulcerative colitis	0.000193	0.000572	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000193	0.000572	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000193	0.00057	CcSEcCtD
Brimonidine—Pain—Hydrocortisone—ulcerative colitis	0.000192	0.00057	CcSEcCtD
Brimonidine—Oedema—Dexamethasone—ulcerative colitis	0.000192	0.000569	CcSEcCtD
Brimonidine—Oedema—Betamethasone—ulcerative colitis	0.000192	0.000569	CcSEcCtD
Brimonidine—Insomnia—Triamcinolone—ulcerative colitis	0.000192	0.000567	CcSEcCtD
Brimonidine—Insomnia—Methylprednisolone—ulcerative colitis	0.000191	0.000566	CcSEcCtD
Brimonidine—Infection—Betamethasone—ulcerative colitis	0.000191	0.000566	CcSEcCtD
Brimonidine—Infection—Dexamethasone—ulcerative colitis	0.000191	0.000566	CcSEcCtD
Brimonidine—Paraesthesia—Triamcinolone—ulcerative colitis	0.00019	0.000563	CcSEcCtD
Brimonidine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.00019	0.000562	CcSEcCtD
Brimonidine—Shock—Betamethasone—ulcerative colitis	0.000189	0.00056	CcSEcCtD
Brimonidine—Shock—Dexamethasone—ulcerative colitis	0.000189	0.00056	CcSEcCtD
Brimonidine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000189	0.000559	CcSEcCtD
Brimonidine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000189	0.000558	CcSEcCtD
Brimonidine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000189	0.000558	CcSEcCtD
Brimonidine—Nausea—Mesalazine—ulcerative colitis	0.000188	0.000557	CcSEcCtD
Brimonidine—Tachycardia—Dexamethasone—ulcerative colitis	0.000188	0.000556	CcSEcCtD
Brimonidine—Tachycardia—Betamethasone—ulcerative colitis	0.000188	0.000556	CcSEcCtD
Brimonidine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000187	0.000552	CcSEcCtD
Brimonidine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000186	0.000551	CcSEcCtD
Brimonidine—Syncope—Prednisone—ulcerative colitis	0.000184	0.000545	CcSEcCtD
Brimonidine—Fatigue—Triamcinolone—ulcerative colitis	0.000183	0.000541	CcSEcCtD
Brimonidine—Fatigue—Methylprednisolone—ulcerative colitis	0.000182	0.00054	CcSEcCtD
Brimonidine—Pain—Triamcinolone—ulcerative colitis	0.000181	0.000536	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisone—ulcerative colitis	0.00018	0.000534	CcSEcCtD
Brimonidine—Hypotension—Betamethasone—ulcerative colitis	0.00018	0.000532	CcSEcCtD
Brimonidine—Hypotension—Dexamethasone—ulcerative colitis	0.00018	0.000532	CcSEcCtD
Brimonidine—Hypertension—Prednisone—ulcerative colitis	0.000177	0.000524	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000175	0.000519	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000175	0.000519	CcSEcCtD
Brimonidine—Arthralgia—Prednisone—ulcerative colitis	0.000175	0.000517	CcSEcCtD
Brimonidine—Myalgia—Prednisone—ulcerative colitis	0.000175	0.000517	CcSEcCtD
Brimonidine—Anxiety—Prednisone—ulcerative colitis	0.000174	0.000515	CcSEcCtD
Brimonidine—Insomnia—Dexamethasone—ulcerative colitis	0.000174	0.000515	CcSEcCtD
Brimonidine—Insomnia—Betamethasone—ulcerative colitis	0.000174	0.000515	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000174	0.000514	CcSEcCtD
Brimonidine—Paraesthesia—Dexamethasone—ulcerative colitis	0.000173	0.000511	CcSEcCtD
Brimonidine—Paraesthesia—Betamethasone—ulcerative colitis	0.000173	0.000511	CcSEcCtD
Brimonidine—Discomfort—Prednisone—ulcerative colitis	0.000173	0.000511	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisolone—ulcerative colitis	0.00017	0.000503	CcSEcCtD
Brimonidine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000169	0.000501	CcSEcCtD
Brimonidine—Dyspepsia—Betamethasone—ulcerative colitis	0.000169	0.000501	CcSEcCtD
Brimonidine—Oedema—Prednisone—ulcerative colitis	0.000167	0.000496	CcSEcCtD
Brimonidine—Infection—Prednisone—ulcerative colitis	0.000166	0.000493	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000166	0.000491	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000166	0.000491	CcSEcCtD
Brimonidine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000166	0.000491	CcSEcCtD
Brimonidine—Fatigue—Dexamethasone—ulcerative colitis	0.000166	0.000491	CcSEcCtD
Brimonidine—Fatigue—Betamethasone—ulcerative colitis	0.000166	0.000491	CcSEcCtD
Brimonidine—Shock—Prednisone—ulcerative colitis	0.000165	0.000488	CcSEcCtD
Brimonidine—Pain—Dexamethasone—ulcerative colitis	0.000164	0.000487	CcSEcCtD
Brimonidine—Pain—Betamethasone—ulcerative colitis	0.000164	0.000487	CcSEcCtD
Brimonidine—Nervous system disorder—Prednisone—ulcerative colitis	0.000164	0.000486	CcSEcCtD
Brimonidine—Tachycardia—Prednisone—ulcerative colitis	0.000163	0.000484	CcSEcCtD
Brimonidine—Skin disorder—Prednisone—ulcerative colitis	0.000163	0.000482	CcSEcCtD
Brimonidine—Asthenia—Hydrocortisone—ulcerative colitis	0.000162	0.000478	CcSEcCtD
Brimonidine—Pruritus—Hydrocortisone—ulcerative colitis	0.000159	0.000471	CcSEcCtD
Brimonidine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000156	0.000462	CcSEcCtD
Brimonidine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000156	0.000461	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000153	0.000452	CcSEcCtD
Brimonidine—Dizziness—Prednisolone—ulcerative colitis	0.000152	0.000451	CcSEcCtD
Brimonidine—Asthenia—Triamcinolone—ulcerative colitis	0.000152	0.00045	CcSEcCtD
Brimonidine—Asthenia—Methylprednisolone—ulcerative colitis	0.000152	0.000449	CcSEcCtD
Brimonidine—Insomnia—Prednisone—ulcerative colitis	0.000151	0.000448	CcSEcCtD
Brimonidine—Paraesthesia—Prednisone—ulcerative colitis	0.00015	0.000445	CcSEcCtD
Brimonidine—Pruritus—Triamcinolone—ulcerative colitis	0.00015	0.000444	CcSEcCtD
Brimonidine—Pruritus—Methylprednisolone—ulcerative colitis	0.00015	0.000443	CcSEcCtD
Brimonidine—Dizziness—Hydrocortisone—ulcerative colitis	0.000149	0.000441	CcSEcCtD
Brimonidine—Dyspepsia—Prednisone—ulcerative colitis	0.000147	0.000436	CcSEcCtD
Brimonidine—Rash—Prednisolone—ulcerative colitis	0.000145	0.00043	CcSEcCtD
Brimonidine—Dermatitis—Prednisolone—ulcerative colitis	0.000145	0.00043	CcSEcCtD
Brimonidine—Fatigue—Prednisone—ulcerative colitis	0.000144	0.000427	CcSEcCtD
Brimonidine—Headache—Prednisolone—ulcerative colitis	0.000144	0.000427	CcSEcCtD
Brimonidine—Rash—Hydrocortisone—ulcerative colitis	0.000142	0.00042	CcSEcCtD
Brimonidine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000142	0.00042	CcSEcCtD
Brimonidine—Headache—Hydrocortisone—ulcerative colitis	0.000141	0.000417	CcSEcCtD
Brimonidine—Dizziness—Triamcinolone—ulcerative colitis	0.00014	0.000415	CcSEcCtD
Brimonidine—Dizziness—Methylprednisolone—ulcerative colitis	0.00014	0.000414	CcSEcCtD
Brimonidine—Asthenia—Dexamethasone—ulcerative colitis	0.000138	0.000408	CcSEcCtD
Brimonidine—Asthenia—Betamethasone—ulcerative colitis	0.000138	0.000408	CcSEcCtD
Brimonidine—Nausea—Prednisolone—ulcerative colitis	0.000137	0.000405	CcSEcCtD
Brimonidine—Pruritus—Betamethasone—ulcerative colitis	0.000136	0.000403	CcSEcCtD
Brimonidine—Pruritus—Dexamethasone—ulcerative colitis	0.000136	0.000403	CcSEcCtD
Brimonidine—Nausea—Hydrocortisone—ulcerative colitis	0.000134	0.000396	CcSEcCtD
Brimonidine—Rash—Triamcinolone—ulcerative colitis	0.000134	0.000396	CcSEcCtD
Brimonidine—Dermatitis—Triamcinolone—ulcerative colitis	0.000134	0.000395	CcSEcCtD
Brimonidine—Rash—Methylprednisolone—ulcerative colitis	0.000133	0.000395	CcSEcCtD
Brimonidine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000133	0.000394	CcSEcCtD
Brimonidine—Headache—Triamcinolone—ulcerative colitis	0.000133	0.000393	CcSEcCtD
Brimonidine—Headache—Methylprednisolone—ulcerative colitis	0.000132	0.000392	CcSEcCtD
Brimonidine—Dizziness—Dexamethasone—ulcerative colitis	0.000127	0.000376	CcSEcCtD
Brimonidine—Dizziness—Betamethasone—ulcerative colitis	0.000127	0.000376	CcSEcCtD
Brimonidine—Nausea—Triamcinolone—ulcerative colitis	0.000126	0.000373	CcSEcCtD
Brimonidine—Nausea—Methylprednisolone—ulcerative colitis	0.000126	0.000372	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisone—ulcerative colitis	0.000123	0.000365	CcSEcCtD
Brimonidine—Rash—Dexamethasone—ulcerative colitis	0.000121	0.000359	CcSEcCtD
Brimonidine—Rash—Betamethasone—ulcerative colitis	0.000121	0.000359	CcSEcCtD
Brimonidine—Dermatitis—Betamethasone—ulcerative colitis	0.000121	0.000359	CcSEcCtD
Brimonidine—Dermatitis—Dexamethasone—ulcerative colitis	0.000121	0.000359	CcSEcCtD
Brimonidine—Headache—Betamethasone—ulcerative colitis	0.00012	0.000357	CcSEcCtD
Brimonidine—Headache—Dexamethasone—ulcerative colitis	0.00012	0.000357	CcSEcCtD
Brimonidine—Asthenia—Prednisone—ulcerative colitis	0.00012	0.000356	CcSEcCtD
Brimonidine—Pruritus—Prednisone—ulcerative colitis	0.000118	0.000351	CcSEcCtD
Brimonidine—Nausea—Betamethasone—ulcerative colitis	0.000114	0.000338	CcSEcCtD
Brimonidine—Nausea—Dexamethasone—ulcerative colitis	0.000114	0.000338	CcSEcCtD
Brimonidine—Dizziness—Prednisone—ulcerative colitis	0.000111	0.000328	CcSEcCtD
Brimonidine—Rash—Prednisone—ulcerative colitis	0.000106	0.000313	CcSEcCtD
Brimonidine—Dermatitis—Prednisone—ulcerative colitis	0.000106	0.000312	CcSEcCtD
Brimonidine—Headache—Prednisone—ulcerative colitis	0.000105	0.000311	CcSEcCtD
Brimonidine—Nausea—Prednisone—ulcerative colitis	9.95e-05	0.000294	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	6.44e-05	0.00322	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—GNA12—ulcerative colitis	6.32e-05	0.00316	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—ADCY5—ulcerative colitis	6.3e-05	0.00315	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CCR6—ulcerative colitis	6.3e-05	0.00315	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—ITGAL—ulcerative colitis	6.2e-05	0.0031	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CCL20—ulcerative colitis	6.1e-05	0.00305	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—PTGER4—ulcerative colitis	5.93e-05	0.00297	CbGpPWpGaD
Brimonidine—AOX1—Disease—MAML2—ulcerative colitis	5.92e-05	0.00296	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.91e-05	0.00296	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.9e-05	0.00295	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—ADCY5—ulcerative colitis	5.89e-05	0.00295	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—PTGER4—ulcerative colitis	5.54e-05	0.00277	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.52e-05	0.00276	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCR2—ulcerative colitis	5.44e-05	0.00272	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—GHRL—ulcerative colitis	5.43e-05	0.00272	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.41e-05	0.00271	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	5.23e-05	0.00262	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCR1—ulcerative colitis	5.18e-05	0.00259	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—GNA12—ulcerative colitis	5.13e-05	0.00257	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CCR6—ulcerative colitis	5.11e-05	0.00256	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—GHRL—ulcerative colitis	5.07e-05	0.00254	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ITGAL—ulcerative colitis	5.04e-05	0.00252	CbGpPWpGaD
Brimonidine—AOX1—Disease—CALM3—ulcerative colitis	4.88e-05	0.00244	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCR1—ulcerative colitis	4.84e-05	0.00242	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—ADCY5—ulcerative colitis	4.78e-05	0.00239	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CHP1—ulcerative colitis	4.74e-05	0.00237	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—CALM3—ulcerative colitis	4.7e-05	0.00235	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCR1—ulcerative colitis	4.7e-05	0.00235	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CCL20—ulcerative colitis	4.54e-05	0.00227	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS1—ulcerative colitis	4.54e-05	0.00227	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—PTGER4—ulcerative colitis	4.5e-05	0.00225	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—ADRB2—ulcerative colitis	4.5e-05	0.00225	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.48e-05	0.00224	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	4.44e-05	0.00222	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—CALM3—ulcerative colitis	4.39e-05	0.0022	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCR1—ulcerative colitis	4.39e-05	0.0022	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—GNA12—ulcerative colitis	4.27e-05	0.00214	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CCL20—ulcerative colitis	4.25e-05	0.00212	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—ADRB2—ulcerative colitis	4.2e-05	0.0021	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	4.15e-05	0.00208	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	4.13e-05	0.00207	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCL20—ulcerative colitis	4.13e-05	0.00207	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—GHRL—ulcerative colitis	4.12e-05	0.00206	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—DLD—ulcerative colitis	4.09e-05	0.00205	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—CALM3—ulcerative colitis	4.09e-05	0.00204	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCR2—ulcerative colitis	4.05e-05	0.00203	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—GNA12—ulcerative colitis	3.99e-05	0.002	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCR1—ulcerative colitis	3.93e-05	0.00197	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—GNA12—ulcerative colitis	3.88e-05	0.00194	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.86e-05	0.00193	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCL20—ulcerative colitis	3.86e-05	0.00193	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CHP1—ulcerative colitis	3.85e-05	0.00193	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CCR6—ulcerative colitis	3.81e-05	0.00191	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCR2—ulcerative colitis	3.78e-05	0.00189	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCR2—ulcerative colitis	3.68e-05	0.00184	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—GNA12—ulcerative colitis	3.62e-05	0.00181	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.6e-05	0.0018	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.59e-05	0.00179	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—CALM3—ulcerative colitis	3.57e-05	0.00179	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCR1—ulcerative colitis	3.57e-05	0.00178	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CCR6—ulcerative colitis	3.56e-05	0.00178	CbGpPWpGaD
Brimonidine—AOX1—Disease—ADCY5—ulcerative colitis	3.54e-05	0.00177	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCR6—ulcerative colitis	3.46e-05	0.00173	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CCL20—ulcerative colitis	3.45e-05	0.00173	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCR2—ulcerative colitis	3.44e-05	0.00172	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—ADRB2—ulcerative colitis	3.41e-05	0.00171	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SEL1L—ulcerative colitis	3.37e-05	0.00169	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	3.37e-05	0.00169	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.36e-05	0.00168	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PTGER4—ulcerative colitis	3.35e-05	0.00168	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.35e-05	0.00168	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—DLD—ulcerative colitis	3.32e-05	0.00166	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—GNA12—ulcerative colitis	3.24e-05	0.00162	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCR6—ulcerative colitis	3.23e-05	0.00162	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—ABCB1—ulcerative colitis	3.18e-05	0.00159	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SEL1L—ulcerative colitis	3.15e-05	0.00158	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PTGER4—ulcerative colitis	3.13e-05	0.00157	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.13e-05	0.00157	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL20—ulcerative colitis	3.13e-05	0.00157	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.07e-05	0.00154	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—GHRL—ulcerative colitis	3.07e-05	0.00154	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PTGER4—ulcerative colitis	3.04e-05	0.00152	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—MMP1—ulcerative colitis	3.02e-05	0.00151	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—ADCY5—ulcerative colitis	2.96e-05	0.00148	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—GNA12—ulcerative colitis	2.94e-05	0.00147	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CCR6—ulcerative colitis	2.89e-05	0.00145	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—GHRL—ulcerative colitis	2.87e-05	0.00143	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.85e-05	0.00143	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PTGER4—ulcerative colitis	2.84e-05	0.00142	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—MMP1—ulcerative colitis	2.82e-05	0.00141	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.81e-05	0.00141	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCR2—ulcerative colitis	2.79e-05	0.0014	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—GHRL—ulcerative colitis	2.79e-05	0.00139	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCR1—ulcerative colitis	2.78e-05	0.00139	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.73e-05	0.00137	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.72e-05	0.00136	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CALM3—ulcerative colitis	2.7e-05	0.00135	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.66e-05	0.00133	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCR6—ulcerative colitis	2.62e-05	0.00131	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.62e-05	0.00131	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—GHRL—ulcerative colitis	2.6e-05	0.0013	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCR1—ulcerative colitis	2.59e-05	0.0013	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	2.56e-05	0.00128	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.54e-05	0.00127	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—ADRB2—ulcerative colitis	2.54e-05	0.00127	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CALM3—ulcerative colitis	2.52e-05	0.00126	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL20—ulcerative colitis	2.44e-05	0.00122	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—ADRB2—ulcerative colitis	2.37e-05	0.00119	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	2.33e-05	0.00117	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	2.31e-05	0.00116	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—ADRB2—ulcerative colitis	2.31e-05	0.00115	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GNA12—ulcerative colitis	2.29e-05	0.00115	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	2.29e-05	0.00115	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—ALB—ulcerative colitis	2.29e-05	0.00115	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL20—ulcerative colitis	2.28e-05	0.00114	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PPARG—ulcerative colitis	2.21e-05	0.00111	CbGpPWpGaD
Brimonidine—AOX1—Disease—JAK2—ulcerative colitis	2.21e-05	0.0011	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCR2—ulcerative colitis	2.17e-05	0.00109	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—CXCL8—ulcerative colitis	2.17e-05	0.00109	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.16e-05	0.00108	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—ADCY5—ulcerative colitis	2.16e-05	0.00108	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—ADRB2—ulcerative colitis	2.16e-05	0.00108	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GNA12—ulcerative colitis	2.14e-05	0.00107	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—ALB—ulcerative colitis	2.14e-05	0.00107	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.13e-05	0.00107	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—JAK2—ulcerative colitis	2.13e-05	0.00106	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	2.12e-05	0.00106	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	2.11e-05	0.00105	CbGpPWpGaD
Brimonidine—AOX1—Disease—CD4—ulcerative colitis	2.09e-05	0.00105	CbGpPWpGaD
Brimonidine—AOX1—Disease—PTGS2—ulcerative colitis	2.08e-05	0.00104	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	2.05e-05	0.00103	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR6—ulcerative colitis	2.04e-05	0.00102	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCR2—ulcerative colitis	2.03e-05	0.00102	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CXCL8—ulcerative colitis	2.03e-05	0.00102	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—ADCY5—ulcerative colitis	2.01e-05	0.00101	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—ALB—ulcerative colitis	1.99e-05	0.000995	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—JAK2—ulcerative colitis	1.99e-05	0.000995	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS1—ulcerative colitis	1.98e-05	0.00099	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—ADCY5—ulcerative colitis	1.96e-05	0.00098	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAML2—ulcerative colitis	1.94e-05	0.000969	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.93e-05	0.000965	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR6—ulcerative colitis	1.91e-05	0.000955	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—IL2—ulcerative colitis	1.86e-05	0.000929	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	1.85e-05	0.000926	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—ADCY5—ulcerative colitis	1.83e-05	0.000916	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAML2—ulcerative colitis	1.81e-05	0.000905	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PTGER4—ulcerative colitis	1.8e-05	0.0009	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CALM3—ulcerative colitis	1.78e-05	0.000892	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.75e-05	0.000876	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	1.74e-05	0.00087	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS2—ulcerative colitis	1.74e-05	0.00087	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ALB—ulcerative colitis	1.74e-05	0.000869	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—IL2—ulcerative colitis	1.73e-05	0.000867	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PTGER4—ulcerative colitis	1.68e-05	0.000841	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	1.65e-05	0.000825	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.65e-05	0.000825	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GHRL—ulcerative colitis	1.65e-05	0.000824	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.64e-05	0.000819	CbGpPWpGaD
Brimonidine—AOX1—Disease—STAT3—ulcerative colitis	1.62e-05	0.00081	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	1.61e-05	0.000808	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	1.61e-05	0.000804	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CALM3—ulcerative colitis	1.59e-05	0.000798	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RIPK2—ulcerative colitis	1.57e-05	0.000786	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	1.55e-05	0.000776	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GHRL—ulcerative colitis	1.54e-05	0.00077	CbGpPWpGaD
Brimonidine—AOX1—Disease—TGFB1—ulcerative colitis	1.5e-05	0.000751	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CALM3—ulcerative colitis	1.49e-05	0.000745	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.49e-05	0.000744	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	1.47e-05	0.000735	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RIPK2—ulcerative colitis	1.47e-05	0.000734	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TGFB1—ulcerative colitis	1.45e-05	0.000724	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CALM3—ulcerative colitis	1.45e-05	0.000724	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—IL2—ulcerative colitis	1.41e-05	0.000705	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ABCB1—ulcerative colitis	1.39e-05	0.000693	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	1.36e-05	0.000683	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	1.36e-05	0.000682	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	1.35e-05	0.000677	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	1.34e-05	0.000673	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ADCY5—ulcerative colitis	1.29e-05	0.000647	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	1.27e-05	0.000637	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	1.26e-05	0.000629	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	1.25e-05	0.000625	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	1.23e-05	0.000614	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	1.22e-05	0.000611	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	1.21e-05	0.000606	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	1.19e-05	0.000596	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TP53—ulcerative colitis	1.19e-05	0.000596	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	1.17e-05	0.000587	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	1.16e-05	0.000579	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	1.15e-05	0.000574	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	1.14e-05	0.000571	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—ulcerative colitis	1.13e-05	0.000566	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	1.13e-05	0.000563	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	1.11e-05	0.000558	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TP53—ulcerative colitis	1.11e-05	0.000557	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	1.1e-05	0.00055	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	1.1e-05	0.000548	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	1.08e-05	0.000541	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	1.07e-05	0.000533	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	1.05e-05	0.000525	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	1.04e-05	0.000521	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	1.03e-05	0.000518	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	1.02e-05	0.000511	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	9.95e-06	0.000498	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—ulcerative colitis	9.64e-06	0.000482	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	9.31e-06	0.000466	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	9.26e-06	0.000464	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TP53—ulcerative colitis	9.04e-06	0.000452	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	8.9e-06	0.000445	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	8.78e-06	0.000439	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—ulcerative colitis	8.67e-06	0.000434	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	8.46e-06	0.000423	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	8.08e-06	0.000404	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—ulcerative colitis	7.83e-06	0.000392	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—ulcerative colitis	7.58e-06	0.000379	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	7.21e-06	0.000361	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—ulcerative colitis	7.04e-06	0.000352	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	6.99e-06	0.00035	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	6.74e-06	0.000337	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	6.58e-06	0.000329	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	6.53e-06	0.000327	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	6.29e-06	0.000315	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	6.26e-06	0.000313	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	6.16e-06	0.000308	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	6.15e-06	0.000308	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	5.95e-06	0.000298	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	5.89e-06	0.000295	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	5.88e-06	0.000294	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	5.85e-06	0.000293	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	5.56e-06	0.000278	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	5.5e-06	0.000275	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	5.47e-06	0.000274	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	5.3e-06	0.000265	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	5.29e-06	0.000265	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	5e-06	0.00025	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	4.95e-06	0.000247	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	4.91e-06	0.000246	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	4.77e-06	0.000239	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	4.75e-06	0.000238	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	4.58e-06	0.000229	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	4.52e-06	0.000226	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	4.47e-06	0.000224	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	4.04e-06	0.000202	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	4.02e-06	0.000201	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	3.77e-06	0.000189	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	3.72e-06	0.000186	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	3.7e-06	0.000185	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	3.45e-06	0.000173	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	3.07e-06	0.000153	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.81e-06	0.00014	CbGpPWpGaD
